Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Mylan NV (NASDAQ:MYL)

30.72
Delayed Data
As of Aug 18
 +0.16 / +0.52%
Today’s Change
29.39
Today|||52-Week Range
49.42
-19.48%
Year-to-Date
Mylan Finalizes Settlement Agreement with DOJ for $465M
Aug 18 / Zacks.com - Paid Partner Content
Why Did Mylan (MYL) Stock Surge Today?
Aug 17 / Zacks.com - Paid Partner Content
Attention Turns to Generic Dynamics After Mylan's EpiPen Medicaid Settlement
Aug 18 / TheStreet.com - Paid Partner Content
Mylan Finalizes $465 Million EpiPen Settlement With DoJ
Aug 17 / TheStreet.com - Paid Partner Content
Pharma Stock Roundup: Multiple Sclerosis Drug Prices in Focus, Mixed Data on BMY's Op...
Aug 18 / Zacks.com - Paid Partner Content
Hikma shares hit by generics business setback
Aug 17 / FT.com - Paid Partner Content
Orbimed Advisors Llc Buys Cigna Corp, Clovis Oncology Inc, Gilead Sciences Inc, Sells...
Aug 17 / GuruFocus News - Paid Partner Content
Generic drugmakers feel pinch as prices crumble
Aug 17 / FT.com - Paid Partner Content
In Hikma's generic race, is third place nowhere?
Aug 17 / FT.com - Paid Partner Content
A Measured Fed and Retail Relief Rally Give Wall Street a Small Lift
Aug 16 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close30.56
Today’s open30.50
Day’s range30.50 - 31.23
Volume7,185,271
Average volume (3 months)5,923,206
Market cap$16.5B
Dividend yield--
Data as of 4:00pm ET, 08/18/2017

Growth & Valuation

Earnings growth (last year)-45.88%
Earnings growth (this year)-6.23%
Earnings growth (next 5 years)+3.21%
Revenue growth (last year)+17.44%
P/E ratio13.2
Price/Sales1.79
Price/Book1.48

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.06-0.07%
PRGOPerrigo Company PLC-0.42-0.54%
JAZZJazz Pharmaceuticals...-1.61-1.10%
INCYIncyte Corp-0.55-0.45%
Data as of 4:01pm ET, 08/18/2017

Financials

Next reporting dateNovember 2, 2017
EPS forecast (this quarter)$1.26
Annual revenue (last year)$11.1B
Annual profit (last year)$480.0M
Net profit margin4.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Executive Director
Heather M. Bresch
President &
Executive Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts